VR Logo

Advanced Enzyme Technologies Ltd.


FMCG | Food Processing

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1989

Chairman: Vasant Rathi

Managing Director: --

Group: --

Listing: NSE: ADVENZYMES, BSE: 540025

Headquarters: Thane, Maharashtra

Website: www.advancedenzymes.com

Key Facts

Market cap: R 4,197.64 Cr

Revenue (TTM): R 478.89 Cr

Earnings (TTM): R 150.35 Cr

Cash: R 206.55 Cr

Total Debt: R 25.55 Cr

Promoters' ownership: 55.38%

Liquidity: High

52 Week range: R 135.00 - 417.00

Face value: R2.00

Shares outstanding: 11,17,28,425

10 Years Aggregate:

  • CFO: 826.16 Cr
  • EBITDA: 1,205.80 Cr
  • Net Profit: 686.84 Cr

Stock Performance

Time Period Advanced Enzyme Technologies S&P BSE FMCG S&P BSE Small Cap
YTD12.140.6914.79
1 month5.600.961.49
3 months15.76-0.3310.84
1 Year139.8017.7190.83
3 Years17.324.674.55
5 Years--9.9613.28
10 Years--13.058.87
As on 20-Apr-2021
Year Advanced Enzyme Technologies S&P BSE Small Cap S&P BSE FMCG
2020103.5032.1110.55
2019-5.86-6.85-3.58
2018-36.14-23.4110.54
2017-30.0459.6431.54